376 related articles for article (PubMed ID: 19132792)
1. Cartilage and bone biomarkers in rheumatoid arthritis: prediction of 10-year radiographic progression.
Syversen SW; Goll GL; van der Heijde D; Landewé R; Gaarder PI; Odegård S; Haavardsholm EA; Kvien TK
J Rheumatol; 2009 Feb; 36(2):266-72. PubMed ID: 19132792
[TBL] [Abstract][Full Text] [Related]
2. Radiographic joint damage in rheumatoid arthritis is associated with differences in cartilage turnover and can be predicted by serum biomarkers: an evaluation from 1 to 4 years after diagnosis.
Verstappen SM; Poole AR; Ionescu M; King LE; Abrahamowicz M; Hofman DM; Bijlsma JW; Lafeber FP;
Arthritis Res Ther; 2006; 8(1):R31. PubMed ID: 16507130
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers.
Young-Min S; Cawston T; Marshall N; Coady D; Christgau S; Saxne T; Robins S; Griffiths I
Arthritis Rheum; 2007 Oct; 56(10):3236-47. PubMed ID: 17907159
[TBL] [Abstract][Full Text] [Related]
4. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
[TBL] [Abstract][Full Text] [Related]
5. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
Nyhäll-Wåhlin BM; Turesson C; Jacobsson LT; Nilsson JÅ; Forslind K; Albertsson K; Rönnelid J; Petersson IF
Scand J Rheumatol; 2011 Mar; 40(2):81-7. PubMed ID: 20919947
[TBL] [Abstract][Full Text] [Related]
6. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis: the COBRA study.
Garnero P; Landewé R; Boers M; Verhoeven A; Van Der Linden S; Christgau S; Van Der Heijde D; Boonen A; Geusens P
Arthritis Rheum; 2002 Nov; 46(11):2847-56. PubMed ID: 12428224
[TBL] [Abstract][Full Text] [Related]
7. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
Syversen SW; Gaarder PI; Goll GL; Ødegård S; Haavardsholm EA; Mowinckel P; van der Heijde D; Landewé R; Kvien TK
Ann Rheum Dis; 2008 Feb; 67(2):212-7. PubMed ID: 17526555
[TBL] [Abstract][Full Text] [Related]
8. Low-dose prednisolone in early rheumatoid arthritis inhibits collagen type I degradation by matrix metalloproteinases as assessed by serum 1CTP--a possible mechanism for specific inhibition of radiological destruction.
Engvall IL; Svensson B; Boonen A; van der Heijde D; Lerner UH; Hafström I;
Rheumatology (Oxford); 2013 Apr; 52(4):733-42. PubMed ID: 23275387
[TBL] [Abstract][Full Text] [Related]
9. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis.
Andersson ML; Svensson B; Petersson IF; Hafström I; Albertsson K; Forslind K; Heinegård D; Saxne T
BMC Musculoskelet Disord; 2013 Aug; 14():229. PubMed ID: 23915292
[TBL] [Abstract][Full Text] [Related]
10. Serological bone markers and joint damage in early polyarthritis.
Jansen LM; van der Horst-Bruinsma I; Lems WF; van Schaardenburg D; van de Stadt R; de Koning M; Dijkmans BA
J Rheumatol; 2004 Aug; 31(8):1491-6. PubMed ID: 15290726
[TBL] [Abstract][Full Text] [Related]
11. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism.
Månsson B; Carey D; Alini M; Ionescu M; Rosenberg LC; Poole AR; Heinegård D; Saxne T
J Clin Invest; 1995 Mar; 95(3):1071-7. PubMed ID: 7533784
[TBL] [Abstract][Full Text] [Related]
12. A cross sectional study of bone and cartilage biomarkers: correlation with structural damage in rheumatoid arthritis.
Ben Achour W; Bouaziz M; Mechri M; Zouari B; Bahlous A; Abdelmoula L; Laadhar L; Sellami M; Sahli H; Cheour E
Libyan J Med; 2018 Dec; 13(1):1512330. PubMed ID: 30160204
[TBL] [Abstract][Full Text] [Related]
13. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction.
Geusens PP; Landewé RB; Garnero P; Chen D; Dunstan CR; Lems WF; Stinissen P; van der Heijde DM; van der Linden S; Boers M
Arthritis Rheum; 2006 Jun; 54(6):1772-7. PubMed ID: 16736519
[TBL] [Abstract][Full Text] [Related]
14. Synovium CD20 expression is a potential new predictor of bone erosion progression in very-early arthritis treated by sequential DMARDs monotherapy -- a pilot study from the VErA cohort.
Lanfant-Weybel K; Michot C; Daveau R; Milliez PY; Auquit-Auckbur I; Fardellone P; Brazier M; Mejjad O; Daragon A; Krzanowska K; Jouen F; Tron F; Le Loarer F; Le Loët X; Vittecoq O
Joint Bone Spine; 2012 Dec; 79(6):574-80. PubMed ID: 22459417
[TBL] [Abstract][Full Text] [Related]
15. Markers for type II collagen breakdown predict the effect of disease-modifying treatment on long-term radiographic progression in patients with rheumatoid arthritis.
Landewé R; Geusens P; Boers M; van der Heijde D; Lems W; te Koppele J; van der Linden S; Garnero P
Arthritis Rheum; 2004 May; 50(5):1390-9. PubMed ID: 15146408
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy.
Niki Y; Takeuchi T; Nakayama M; Nagasawa H; Kurasawa T; Yamada H; Toyama Y; Miyamoto T
PLoS One; 2012; 7(5):e37447. PubMed ID: 22629396
[TBL] [Abstract][Full Text] [Related]
17. Osteoarthritis, magnetic resonance imaging, and biochemical markers: a one year prospective study.
Bruyere O; Collette J; Kothari M; Zaim S; White D; Genant H; Peterfy C; Burlet N; Ethgen D; Montague T; Dabrowski C; Reginster JY
Ann Rheum Dis; 2006 Aug; 65(8):1050-4. PubMed ID: 16396978
[TBL] [Abstract][Full Text] [Related]
18. Serum pyridinoline levels and prediction of severity of joint destruction in rheumatoid arthritis.
Krabben A; Knevel R; Huizinga TW; Cavet G; van der Helm-van Mil AH
J Rheumatol; 2013 Aug; 40(8):1303-6. PubMed ID: 23729802
[TBL] [Abstract][Full Text] [Related]
19. Arthritis instantaneously causes collagen type I and type II degradation in patients with early rheumatoid arthritis: a longitudinal analysis.
Landewé RB; Geusens P; van der Heijde DM; Boers M; van der Linden SJ; Garnero P
Ann Rheum Dis; 2006 Jan; 65(1):40-4. PubMed ID: 16126801
[TBL] [Abstract][Full Text] [Related]
20. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
Lindqvist E; Eberhardt K; Bendtzen K; Heinegård D; Saxne T
Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
